CREATE
Active not recruiting
712 enrolled
Imfinzi/Imjudo NSCLC Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - CEI/SCEI
Completed
296 enrolled
Real-World Outcomes of First-Line Nivolumab + Ipilimumab With Chemotherapy in Non-Small Cell Lung Cancer in Poland
Completed
240 enrolled
TraveraRTGx
Completed
72 enrolled
ENTIRETY
Active not recruiting
50 enrolled
A Study of Participants in China With Non-Small-Cell Lung Cancer That is Unable to be Treated With Surgery
Active not recruiting
1,200 enrolled
Identification and Validation of Blood-Based Biomarkers for Early Detection of Asymptomatic Lung Cancer in High-Risk Heavy Smokers
Recruiting
350 enrolled
LEPIDOPTERA
Recruiting
380 enrolled
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
Completed
140 enrolled
Real World Evaluation of Sotorasib Among Chinese Non-Small Cell Lung Cancer Patients
Completed
102 enrolled
LARCS
Recruiting
512 enrolled
Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant Therapy
Recruiting
800 enrolled
SHIELD
Active not recruiting
12,000 enrolled
MK-3475-U01
Recruiting
1,065 enrolled
TEMPUS Small Cell Lung Cancer OBSERVATIONAL STUDY (Sculptor)
Recruiting
200 enrolled
DREAM
Recruiting
200 enrolled
A Study to Learn About Dacomitinib in Patients With Non-small Cell Lung Cancer.
Active not recruiting
29 enrolled
DP-04
Recruiting
100 enrolled
Safety and Efficacy of Xalkori ROS1
Active not recruiting
97 enrolled
NAUTIC
Recruiting
600 enrolled
Post Marketing Surveillance(PMS) Study of Lorviqua in Korea
Recruiting
600 enrolled
A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice
Recruiting
700 enrolled
CHOICE
Recruiting
590 enrolled
European Real-World Registry for Use of the Ion Endoluminal System
Recruiting
1,200 enrolled
CASCADE
Recruiting
600 enrolled
UmbREALung
Recruiting
300 enrolled
Pan HER2
Recruiting
2,100 enrolled
DELFI-L201
Active not recruiting
11,935 enrolled
RACE-2L
Recruiting
250 enrolled
CEMI-LUNG
Recruiting
500 enrolled
Survey of Brigatinib Used To Treat People With Non-Small Cell Lung Cancer
Recruiting
500 enrolled
NIS durvalumab
Active not recruiting
250 enrolled
ORI-EGI-03
Recruiting
450 enrolled
LUSIP
Not yet recruiting
477 enrolled
Lung Cancer Screening Program Using Low-dose Tomography and Metabolomic Evaluation in a Public Service.
Recruiting
1,000 enrolled
PMCF Study of the CE-marked Drainova® ArgentiC Catheter
Completed
169 enrolled
A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer Which Could Not Be Controlled
Completed
73 enrolled 12 charts
UNCOVER
Completed
833 enrolled
OSIREAL
Recruiting
500 enrolled
Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
Recruiting
130 enrolled
LUNG-ROLL
Recruiting
60,000 enrolled
SCLC
Completed
272 enrolled
Treatment and Biomarker Testing Patterns,Treatment Outcomes in a/m NSCLC With and Without Actionable Genomic Alterations
Active not recruiting
1,500 enrolled
ARSENAL
Active not recruiting
254 enrolled
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
Recruiting
25 enrolled
DeniLA
Recruiting
200 enrolled
Brilliant
Active not recruiting
154 enrolled
BASECAMP-1
Recruiting
200 enrolled
Korea Post Marketing Surveillance (PMS) Study of Vizimpro
Completed
188 enrolled
GEMINI-NSCLC: NSCLC Biomarker Study
Recruiting
1,200 enrolled